Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Petros Pharmaceuticals, Inc. (PTPI) had Earnings per Share (EPS) (Basic) of $-0.03 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.15M |
|
-- |
|
-- |
|
$0.99M |
|
$-0.99M |
|
$0.07M |
|
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-0.99M |
|
$-0.99M |
|
42.28M |
|
42.28M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.03 |
$-0.03 |
|
| Balance Sheet Financials | |
$6.13M |
|
-- |
|
-- |
|
$6.13M |
|
$2.77M |
|
-- |
|
-- |
|
$2.77M |
|
$3.37M |
|
$3.37M |
|
$3.37M |
|
42.28M |
|
| Cash Flow Statement Financials | |
$-5.80M |
|
-- |
|
$8.16M |
|
$3.71M |
|
$6.07M |
|
$2.36M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.40% |
|
-27.40% |
|
-15.04% |
|
-27.40% |
|
$0.08 |
|
$-0.14 |
|
$-0.14 |
|